Concepedia
Statistics
Publications
20
Citations
1.6K
H-Index
16
Active since
2016
Affiliations
Universitätsklinikum Würzburg(Current)
Comprehensive Cancer Center Mainfranken
University of Würzburg
Charité - Universitätsmedizin Berlin
Heidelberg University
Maria-Elisabeth Goebeler is an author at Universitätsklinikum Würzburg specializing in medicine, oncology, and immunotherapy.
Top concepts
MedicineOncologyImmunologyImmunotherapyPathologyPharmacologyTumor BiologyCancer TherapyTumor ImmunityRadiation Oncology
Publications per year
2016–2024
Bispecific T-Cell Engager (BiTE) Antibody Construct Blinatumomab for the Treatment of Patients With Relapsed/Refractory Non-Hodgkin Lymphoma: Final Results From a Phase I Study
Maria-Elisabeth Goebeler, Stefan Knop, Andreas Viardot et al. · Journal of Clinical Oncology · 2016 · 414 citations
Homozygous BCMA gene deletion in response to anti-BCMA CAR T cells in a patient with multiple myeloma
Matteo Da Vià, Oliver Dietrich, Marietta Truger et al. · Nature Medicine · 2021 · 314 citations
Hematological Malignancy, Autoimmune Disease, Malignant Blood Disorder +8
Proof of concept for a rapidly switchable universal CAR-T platform with UniCAR-T-CD123 in relapsed/refractory AML
Martin Wermke, Sabrina Kraus, Armin Ehninger et al. · Blood · 2021 · 160 citations · Full text
Relapsed/refractory Aml, Automotive Electronics, Engineering +1
Pasotuxizumab, a Bite <sup>®</sup> Immune Therapy for Castration-Resistant Prostate Cancer: Phase I, Dose-Escalation Study Findings
Horst-Dieter Hummel, Peter Kufer, Carsten Grüllich et al. · Immunotherapy · 2020 · 132 citations · Full text
Long-term outcome of patients with relapsed/refractory B-cell non-Hodgkin lymphoma treated with blinatumomab
Vera Dufner, Cyrus Sayehli, Manik Chatterjee et al. · Blood Advances · 2019 · 88 citations · Full text
1–5 of 20